Clinical Utility of Cxbladder to Headline at the 2024 AUA Annual Meeting

A ground-breaking study demonstrating the clinical utility of Cxbladder is to be the centrepiece of cancer diagnostics company Pacific Edge's (NZX, ASX: PEB) activities at the 2024 American Urological Association (AUA) Annual Meeting to be held May 3 – 6 in San Antonio, Texas. HERSHEY, Pa....
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI FVT Source Type: news